Correspondence
The potential danger of journal summary services
Abstract
On 29 April, NEJM Journal Watch published a summary of a recent trial of single-dose dexamethasone for acute asthma compared with the current standard of 5-day prednisone. Unfortunately the one-line opening paragraph of the summary (which was the only line in the email alert) stated the opposite of the actual outcome of the trial. It is conceivable that practitioners around the world might change their practice on the basis of this one-line summary, with grave consequences.
Author's affiliations
Timo Freeth, Cape Town, South Africa
Full Text
PDF (42KB)Keywords
Jurnal summary services; NEJM Journal Watch; Single-dose dexamethasone
Cite this article
South African Medical Journal 2016;106(9):842.
DOI:10.7196/SAMJ.2016.v106i9.11088
Article History
Date submitted: 2016-05-26
Date published: 2016-08-08
Date published: 2016-08-08
Article Views
Abstract views: 2461
Full text views: 832
Full text views: 832
Comments on this article
*Read our policy for posting comments here